Breaks Categories: News

TuesdayNov 09, 2021 1:20 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Merger Completion, New Appointments as Business Scales

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its reverse merger transaction with Net Element is now complete. According to the update, the combined company will operate under the name Mullen Automotive Inc., with shares of Mullen Automotive now trading on the Nasdaq Capital Market under the ticker symbol MULN. “We are excited to have completed this merger and our transition to a public company and welcome the Net Element shareholders to Mullen,” said Mullen Automotive CEO and Chairman David Michery. “With the completion of this corporate action, we believe that we are well positioned…

Continue Reading

TuesdayNov 09, 2021 1:04 pm

NetworkNewsBreaks – Astra Energy Inc. (ASRE) Enters Agreement for Rights to Patented Waste-to-Energy Technology

Astra Energy (OTC: ASRE), a renewable and waste-to-energy project developer and technology acquisition company, has secured rights for a proprietary waste-to-energy technology. The rights were obtained through an agreement the company entered between Regreen Technologies Inc. and Global Sustainable Technologies Inc. Regreen owns a patented process that turns solid waste material into a marketable product. According to the agreement, has exclusive rights to the technology in Africa, Jamaica, Brazil and Canada, as well as priority in terms of equipment supply and delivery. The company also noted that a pilot project to demonstrate a working model of the system is nearing completion. “We are excited to…

Continue Reading

TuesdayNov 09, 2021 12:55 pm

NetworkNewsBreaks – Vision Hydrogen Corporation (VIHD) Completes Acquisition of Hydrogen Producer Volth2

Vision Hydrogen (OTCQB: VIHD) has acquired VoltH2 Holdings AG, one of Western Europe’s leading developers of hydrogen production facilities and infrastructure. The transaction involved Vision Hydrogen acquiring the remaining 84.1% interest of VoltH2; combined with the 15.9% interest the company owned previously, VIHD now owns 100% of VoltH2. In conjunction with the acquisition, several appointments were also announced. Andrew Hromyk and Andre Jurres have been named Vision Hydrogen’s co-CEOs and will also serve as directors. Arron Smyth has been appointed executive vice president of corporate development, and Andy Hidalgo, Vision Hydrogen’s former CEO, will serve as senior vice president; Hidalgo also…

Continue Reading

TuesdayNov 09, 2021 12:43 pm

NetworkNewsBreaks – DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) CEO Discusses Game-Changing AI in Latest Episode of ‘Bell2Bell’ Podcast

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, was featured in the “Bell2Bell Podcast,” a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. DigiMax’s CEO Chris Carl joined the latest episode to discuss the company’s history and business model focused on applying AI across various industries and verticals. “As we rolled forward, because we also have financial backgrounds, we were interested in how we could better use blockchain, security tokens and efficiency of markets that results from those. As we worked through that, we saw…

Continue Reading

TuesdayNov 09, 2021 12:25 pm

NetworkNewsBreaks – Hudson Global, Inc. (NASDAQ: HSON) Featured in Research Note from Sidoti

Price Target Raised; Estimates Raised Hudson Global, Inc. (NASDAQ: HSON) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Raise Target To $44 (From $31); 3Q:21 Results Confirm HSON’s RPO Business Has Hit An Inflection Point; Meaningfully Higher 2022 Outlook Reflects Enhanced Operating Leverage, Recent Acquisition.” Click here to access the full report. About Hudson Global, Inc. Hudson Global is a leading global total talent solutions provider operating under the brand name Hudson RPO. We deliver innovative, customized recruitment outsourcing and total talent solutions to organizations worldwide. Through our consultative approach,…

Continue Reading

TuesdayNov 09, 2021 10:41 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Release Q2 2021 Financial Results, Host Call

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing Psychedelics to Therapeutics(TM), is planning to release its Q2 2021 financial report on Nov. 15, 2021. The report will cover the period ended Sept. 30, 2021. The company  is also planning on hosting a conference call and webcast the same day, which is scheduled to begin at 4:30 p.m. EST. The call will be hosted by Cybin CEO Doug Drysdale and will provide an overview of the financial results along with relevant business updates. In addition, Drysdale and other team members will answer questions during the call. Those who…

Continue Reading

TuesdayNov 09, 2021 10:21 am

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Scheduled Release of Q3 2021 Financial Results, Conference Call

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring in adults, today announced that it plans to release financial results for the third quarter ended Sept. 30, 2021, after market close on Monday, Nov. 15, 2021. Vivos will host a conference call the same day at 5:00 p.m. Eastern Time to review the results and provide an overview of the company’s recent milestones and growth strategy. Interested parties may access a live webcast via the Vivos’ website and join the…

Continue Reading

TuesdayNov 09, 2021 9:56 am

NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces Completion of Ketamine Wellness Centers Acquisition

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has completed the acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”). The completion firmly establishes Delic as the largest chain of wellness centers that provide ketamine treatments in the United States. Delic now offers access to new medicines and treatments through 12 operational clinics spread across 10 states, including Arizona, Colorado, Florida, Illinois, Minnesota, Nevada, Texas, Utah. The company anticipates opening 15 additional clinics in the next 18 months. In addition, Kevin Nicholson, KWC CEO, was appointed chief operating officer at…

Continue Reading

MondayNov 08, 2021 3:11 pm

NetworkNewsBreaks – NFT Genius, Dapper Wallet Partnership Offers Unprecedented Marketplace Experience

NFT Genius, a game-changing presence and pioneer, is making history in the crypto space. The company is one of the first — if not the first — to integrate the Dapper Wallet with its Gaia marketplace. The milestone partnership offers wallet users unprecedented access, ease and flexibility to take full advantage of the opportunities in the NFT market. “No one has ever been given access to the Dapper Wallet before,” NFT Genius CEO Jeremy Born said in the news release. “We’ve been in partnership with Dapper for a while now, working to create a quality, seamless marketplace experience. We’re thrilled…

Continue Reading

MondayNov 08, 2021 2:50 pm

NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Additional Order as Its Ecosystem Continues to Power Trials, Pilots and Studies in Plant-Based Medicine

RYAH Group (CSE: RYAH) today announced its receipt of an additional order for future shipments of hundreds of its proprietary RYAH Smart Dry Herb Inhalers and accessories to its United Kingdom-based industry partner, an international clinic undertaking one of the world’s largest and most comprehensive clinical trials in plant-based medicine. The order follows the recently announced initial shipment, and the devices will be used by a growing number of participants of the major U.K.-based clinical trial. Over the next five years, the trial is planned to engage tens of thousands of United Kingdom patients and aims to focus on studying the…

Continue Reading